Vertex Pharmaceuticals
VRTX
$455.34
Share price
2.77%
Change (1 day)
40.72%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - P/B ratio
P/B ratio as of June 2024 : 6.16
According to Vertex Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 6.16.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Vertex Pharmaceuticals - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 5.96 | 11.94% |
| 2022-12-31 | 5.33 | -3.71% |
| 2021-12-31 | 5.53 | -21.79% |
| 2020-12-31 | 7.07 | -24.08% |
| 2019-12-31 | 9.32 | -2.26% |
| 2018-12-31 | 9.53 | -48.63% |
| 2017-12-31 | 18.6 | 35.91% |
| 2016-12-31 | 13.7 | -51.82% |
| 2015-12-31 | 28.3 | 8.16% |
| 2014-12-31 | 26.2 | 104.6% |
| 2013-12-31 | 12.8 | 68.21% |
| 2012-12-31 | 7.61 | 2.05% |
| 2011-12-31 | 7.46 | -47.27% |
| 2010-12-31 | 14.1 | 81.01% |
| 2009-12-31 | 7.82 | -56.58% |
| 2008-12-31 | 18.0 | 58.2% |
| 2007-12-31 | 11.4 | 21.97% |
| 2006-12-31 | 9.33 | -25.45% |
| 2005-12-31 | 12.5 | -48.06% |
| 2004-12-31 | 24.1 | 475.21% |
| 2003-12-31 | 4.19 | 30.99% |
| 2002-12-31 | 3.20 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.99 | -19.00% | 🇺🇸 USA |
 AbbVie ABBV | 34.3 | 456.44% | 🇺🇸 USA |
 Gilead Sciences GILD | 4.57 | -25.81% | 🇺🇸 USA |
 Merck MRK | 7.89 | 27.97% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 4.93 | -20.02% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | 1.53 | -75.18% | 🇺🇸 USA |